Tumor intrinsic subtype is reflected in cancer-adjacent tissue

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 2, 2015, Pages 406-414

  Casbas Hernandez, Patricia ^a   Sun, Xuezheng ^b   Roman Perez, Erick ^b   D'Arcy, Monica ^b   Sandhu, Rupninder ^c   Hishida, Asahi ^c   McNaughton, Kirk K ^a   Yang, Xiaohong R ^d   Makowski, Liza ^c,e   Sherman, Mark E ^d   Figueroa, Jonine D ^d   Troester, Melissa A ^a,b,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e University of North Carolina   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJACENT TISSUE; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER TISSUE; CELL COMMUNICATION; COCULTURE; CONTROLLED STUDY; FEMALE; FIBROBLAST; FROZEN SECTION; GENE EXPRESSION PROFILING; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MASTECTOMY; MICROARRAY ANALYSIS; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RECURRENCE RISK; TISSUES; TRIPLE NEGATIVE BREAST CANCER; TUMOR MICROENVIRONMENT; BREAST TUMOR; GENE; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; TISSUE MICROARRAY; TUMOR INVASION; TUMOR RECURRENCE; YOUNG ADULT;

ADULT; AGED; BIOMARKERS, TUMOR; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MHC CLASS II; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; TISSUE ARRAY ANALYSIS; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR MICROENVIRONMENT; YOUNG ADULT;

EID: 84922755274     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0934     Document Type: Article

References (49)

1. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1227-32.
2. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.
3. Silverstein MJ, Lagios MD, Groshen S, Waisman JR, Lewinsky BS, Martino S, et al. The influenceofmarginwidthonlocal control ofductal carcinoma in situ of the breast. N Engl J Med 1999;340:1455-61.
4. Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, et al. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Int J Radiat Oncol Biol Phys 2005;63:1514-21.
5. Bijker N, Peterse JL, Duchateau L, Julien JP, Fentiman IS, Duval C, et al. Risk factor for recurrence and metastasis after BCT for DCIS. Analysis of European organization for research and treatment of cancer trial 10853. J Clin Oncol 2001;19:2263-71.
6. Arvold ND, Taghian AG, Niemierko A, Abi Raad RF, Sreedhara M, Nguyen PL, et al. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol 2011;29:3885-91.
7. Pirone JR, D'Arcy M, Stewart DA, Hines WC, Johnson M, Gould MN, et al. Age-associated gene expression in normal breast tissue mirrors qualitative age-at-incidence patterns for breast cancer. Cancer Epidemiol Biomarkers Prev 2012;21:1735-44.
8. Voduc KD, Cheang MCU, Tyldesley S, Gelmon K, Nielsen TO, Kennecke H. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 2010;28:1684-91.
9. Gabos Z, Thoms J, Ghosh S, Hanson J, Deschanes J, Sabri S, et al. The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer. Breast Cancer Res Treat 2010;124:187-94.
10. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006;6: 392-401.
11. Albini A, Sporn MB. The tumour microenvironment as a target for che-moprevention. Nat Rev Cancer 2007;7:139-47.
12. De Wever O, Demetter P, Mareel M, Bracke M. Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 2008;123:2229-38.
13. Bissell MJ, Kenny PA, Radisky DC. Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes. Cold Spring Harb Symp Quant Biol 2005;70:343-56.
14. Camp JT, Elloumi F, Roman-Perez E, Rein J, Stewart DA, Harrell JC, et al. Interactions with fibroblasts are distinct in basal-like and luminal breast cancers. Mol Cancer Res 2011;9:3-13.
15. Troester MA, Lee MH, Carter M, Fan C, Cowan DW, Perez ER, et al. Activation of host wound responses in breast cancer microenvironment. Clin Cancer Res 2009;15:7020-8.
16. Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 2008;14:518-27.
17. Roman-Perez E, Casbas-Hernandez P, Pirone J, Rein J, Carey L, Lubet R, et al. Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients. Breast Cancer Res 2011;14:R51.
18. Yang X, Figueroa J, Falk R, Zhang H, Pfeiffer R, Hewitt S, et al. Analysis of terminal duct lobular unit involution in luminal a and basal breast cancers. Breast Cancer Res 2013;14:R64.
19. Graham K, Ge X, de las Morenas A, Tripathi A, Rosenberg CL. Gene expression profiles of estrogen receptor positive and estrogen receptor negative breast cancers are detectable in histologically normal breast epithelium. Clin Cancer Res 2011;17:236-46.
20. Casbas-Hernandez P, D'Arcy M, Roman-Perez E, Brauer H, McNaughton K, Miller S, et al. Role of hgf in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ. Breast Cancer Res 2013;15:R82.
21. Sundaram S, Freemerman A, Johnson A, Milner JJ, McNaughton K, Galanko J, et al. Role of hgf in obesity-associated tumorigenesis: C3(1)-tag mice as a model for human basal-like breast cancer. Breast Cancer Res Treat 2013;142:489-503.
22. García-Closas M, Brinton LA, Lissowska J, Chatterjee N, Peplonska B, Anderson WF, et al. Established breast cancer risk factors by clinically important tumour characteristics. Br J Cancer 2006;95:123-9.
23. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012;490:61-70.
24. Parker JS, Mullins M, Cheang MCU, Leung S, Voduc D, Vickery T, et al. Supervised risk predictor ofbreast cancer based on intrinsic subtypes. J Clin Oncol 2009;27:1160-7.
25. Prat A, Parker J, Karginova O, Fan C, Livasy C, Herschkowitz J, et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 2010;12:R68.
26. Sun X, Gierach GL, Sandhu R, Williams T, Midkiff BR, Lissowska J, et al. Relationship of mammographic density and gene expression: analysis of normal breast tissue surrounding breast cancer. Clin Cancer Res 2013;19: 4972-82.
27. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci 2001;98: 5116-21.
28. Elloumi F, Hu Z, Li Y, Parker J, Gulley M, Amos K, et al. Systematic bias in genomic classification due to contaminating non-neoplastic tissue in breast tumor samples. BMC Med Genomics 2011;4:54.
29. Creighton CJ, Casa A, Lazard Z, Huang S, Tsimelzon A, Hilsenbeck SG, et al. Insulin-like growth factor-i activates gene transcription programs strongly associated with poor breast cancer prognosis. J Clin Oncol 2008;26: 4078-85.
30. Oh DS, Troester MA, Usary J, Hu Z, He X, Fan C, et al. Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers. J Clin Oncol 2006;24:1656-64.
31. Troester MA, Hoadley KA, Sùrlie T, Herbert B-S, Bùrresen-Dale A-L, Lùnning PE, et al. Cell-type-specific responses to chemotherapeutics in breast cancer. Cancer Res 2004;64:4218-26.
32. Proia DA, Kuperwasser C. Reconstruction of human mammary tissues in a mouse model. Nat Protocols 2006;1:206-14.
33. Buess M, Nuyten D, Hastie T, Nielsen T, Pesich R, Brown P. Characterization of heterotypic interaction effects in vitro to deconvolute global gene expression profiles in cancer. Genome Biol 2007;8:R191.
34. Buess M, Rajski M, Vogel-Durrer BM, Herrmann R, Rochlitz C. Tumor-endothelial interaction links the cd44/cd24(-) phenotype with poor prognosis in early-stage breast cancer. Neoplasia 2009;10: 987-1002.
35. Yang X, Figueroa J, Hewitt S, Falk R, Pfeiffer R, Lissowska J, et al. Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer. Breast Cancer Res Treat 2013:137:837-47.
36. Meyers M, Klauber-DeMore N, Ollila D, Amos K, Moore D, Drobish A, et al. Impact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer. Ann Surg Oncol 2011;18:2851-7.
37. Stewart DA, Yang Y, Makowski L, Troester MA. Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages. Mol Cancer Res 2012;10:727-38.
38. Sansone P, Storci G, Tavolari S, Guarnieri T, Giovannini C, Taffurelli M, et al. Il-6 triggers malignant featuresinmammospheresfrom humanductal breast carcinoma and normal mammary gland. J Clin Invest 2007;117: 3988-4002.
39. Campbell M, Tonlaar N, Garwood E, Huo D, Moore D, Khramtsov A, et al. Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome. Breast Cancer Res Treat 2011;128:703-11.
40. DeNardo DG, Barreto JB, Andreu P, Vasquez L, Tawfik D, Kolhatkar N, et al. Cd4t cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009;16:91-102.
41. Khan S, Rogers MA, Obando JA, Tamsen A. Estrogen receptor expression of benign epithelium and its association with breast cancer. Cancer Res 1994;54:993-7
42. Khan S, Rogers MA, Khurana KK, Numann PJ. Estrogen receptor expression in benign breast epithelium and breast cancer risk. J Nat Cancer Inst 1998;90:37-42.
43. Largent JA, Capanu M, Bernstein L, Langholz B, Mellemkaer L, Malone KE, et al. Reproductive history and risk of second primary breast cancer: the WECARE study. Cancer Epidemiol Biomarkers Prev 2007;16:906-11.
44. Begg CB, Berwick M. A note on the estimationof relative risks of rare genetic susceptibility markers. Cancer Epidemiol Biomarkers Prev 1997;6:99-103.
45. Ma X-J, Dahiya S, Richardson E, Erlander M, Sgroi D. Gene expression profilingofthe tumormicroenvironment during breast cancer progression. Breast Cancer Res 2009;11:R7.
46. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004;6:17-32.
47. Haslam S, Woodward T. Host microenvironment in breast cancer development: epithelial-cell-stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland. Breast Cancer Res 2003;5:208-15.
48. Luciani MG, Seok J, Sayeed A, Champion S, Goodson WH, Jeffrey SS, et al. Distinctive responsiveness to stromal signaling accompanies histologic grade programming of cancer cells. PLoS ONE 2011;6:e20016.
49. Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K, et al. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2004;2:e7.